Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Control of human toxoplasmosis
Toxoplasmosis is caused by Toxoplasma gondii, an apicomplexan parasite that is able to
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …
[HTML][HTML] Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis
Y Zhang, BS Lai, M Juhas, Y Zhang - Microbiological research, 2019 - Elsevier
T. gondii is a major opportunistic pathogen chronically infecting nearly one third of the
world's population. Due to the high infection and mortality rates in immunocompromised …
world's population. Due to the high infection and mortality rates in immunocompromised …
Toxoplasma gondii vaccine candidates: a concise review
Toxoplasma gondii is an obligate intracellular parasite that causes toxoplasmosis. It has
been shown that the severity of symptoms depends on the functioning of the host immune …
been shown that the severity of symptoms depends on the functioning of the host immune …
[PDF][PDF] Rhoptry antigens as Toxoplasma gondii vaccine target
Toxoplasmosis is a cosmopolitan zoonotic infection, caused by a unicellular protozoan
parasite known as Toxoplasma gondii that belongs to the phylum Apicomplexa. It is …
parasite known as Toxoplasma gondii that belongs to the phylum Apicomplexa. It is …
[PDF][PDF] Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention
M Foroutan, F Ghaffarifar, NJC Robles… - Clinical and …, 2018 - synapse.koreamed.org
Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic
infection in wide range of intermediate hosts. Over one-third of the world's population are …
infection in wide range of intermediate hosts. Over one-third of the world's population are …
Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against …
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed;
however, a protective vaccine using immunogenic peptides in a safe delivery vehicle system …
however, a protective vaccine using immunogenic peptides in a safe delivery vehicle system …
Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii
C Brito, C Lourenço, J Magalhães, S Reis, M Borges - Vaccines, 2023 - mdpi.com
Nanoparticles include particles ranging in size from nanometers to micrometers, whose
physicochemical characteristics are optimized to make them appropriate delivery vehicles …
physicochemical characteristics are optimized to make them appropriate delivery vehicles …
Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications
JP Assolini, VM Concato, MD Gonçalves… - Parasitology …, 2017 - Springer
Toxoplasmosis is an infectious disease caused by the intracellular parasite Toxoplasma
gondii that affects about one third of the world's population. The diagnosis of this disease is …
gondii that affects about one third of the world's population. The diagnosis of this disease is …
[HTML][HTML] Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine
Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic
infection in wide range of intermediate hosts. Over one-third of the world's population are …
infection in wide range of intermediate hosts. Over one-third of the world's population are …
Nano dimensions/adjuvants in COVID-19 vaccines
E Alphandéry - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
A favorable outcome of the COVID-19 crisis might be achieved with massive vaccination.
The proposed vaccines contain several different vaccine active principles (VAP), such as …
The proposed vaccines contain several different vaccine active principles (VAP), such as …